Expression of three receptors—estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2)—are routinely used to determine optimal treatment plans for breast cancer patients [4]. The gene discussed is PGR; the disease is breast carcinoma.